Lupin Limited (LUPIN) — Voting Results | 26 August 2025

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Lupin Limited conducted postal ballot voting on two resolutions: (1) re-appointment of Mr. Mark D. McDade as Independent Director for a second five-year term (January 28, 2026–January 27, 2031) as a Special Resolution, and (2) approval of remuneration revision for Managing Director Mr. Nilesh D. Gupta effective October 1, 2025, as an Ordinary Resolution. E-voting runs August 27–September 25, 2025, with results declared by September 29, 2025. McDade brings 37+ years biopharmaceutical expertise; Gupta's revised remuneration reflects strong 5-year financial performance and peer benchmarking showing compensation in the bottom 20% of comparable pharma executives.

📄 View Original Announcement (PDF)

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

📊 More LUPIN filings

See all LUPIN filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LUPIN — Free

Free account · 2 AI queries/day